In cardiovascular disease, GDF15 has great potential as a biomarker for prognosis and as a protective cytokine against different stimuli via specific signaling pathways, such as PI3K/Akt, ERK1/2, and SMAD2/3 [14], [15], [16], [17], [18], [19]. This evidence concerns the gene AKT1 and cardiovascular disorder.